Series A
Investment Notes: Elyos
Blackbird's post explains why it led Elyos's Series A with PiLabs, YC and 468 Capital, profiling the AI phone-agent startup for trade businesses, its traction and its three founders.
Company
Oxford
Oxford
Funding history
Investors
Every investor coverage indicates participated in a round Oxford raised.
What Oxford bought
Companies Oxford acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
People
| Name | Role | Sources |
|---|---|---|
| Professor Mark Kendall | Lecturer (former) | @AuManufacturing (Sun 19 Jan 2025), @AuManufacturing (Mon 1 Jun 2020) |
Coverage
Stories naming Oxford. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
2 deals
Inside Ochre: a new startup program for First Nations entrepreneurs
Profile of Dr Kyle Turner launching the LaunchVic-funded Ochre pre-accelerator for First Nations founders, recalling his dental AI startup Pearlii and his role at a new First Nations venture fund.
2 deals
Indigenous founder focused VC Ochre Ventures hits $30 million first close on $100m target
First Nations-focused venture firm Ochre Ventures has closed the first tranche of its debut fund at $30m against a $100m goal, with PSG Holdings, MicroProse and Xylo Systems among five early investments.
Unnamed stage
$3m+
Inside Ochre – here’s what you need to know about a new pre-accelerator program for First Nations entrepreneurs
Profile of Dr Kyle Turner, who is building Ochre, a LaunchVic-backed pre-accelerator for First Nations founders, and previously raised $3m-plus for dental AI startup Pearlii.
Also Startup Daily·LaunchVic
Unnamed stage
$50k
How to fill holes in dental care … without seeing a dentist
Profile of Pearlii founder Kyle Turner, whose Melbourne AI dental-checkup app followed a 2019 Dream Ventures pitch, tracing his journey from Dubbo to Oxford and the company's pivot to dental products.
Pre-seed
Investment Notes: Samphire Neuroscience
AfterWork Ventures explains why it invested pre-seed in Samphire Neuroscience, a neurotech startup whose headband eases menstrual symptoms, alongside hardware accelerator HAX, profiling the Oxford-founded team and the women's health opportunity.
Also Startup Daily
Seed
$2.5m
Investment Notes: Jupiter Ionics
Tenacious Ventures' investment note on its participation in Jupiter Ionics' AUD 2.5 million seed round; the startup develops carbon-neutral ammonia production using technology invented at Monash University.
News
Slowly getting closer to the pointy end
Profile of Brisbane medtech firm Vaxxas on scaling its needle-free vaccine patch from prototype toward commercial manufacture, with pharma partner Merck and production specialist Harro Hofliger announced as collaborators.
Unnamed stage
$1.5m
EvokeAg 2020: Sparks as meat and plant protein share same stage
Conference report from Melbourne where plant-based and conventional protein advocates debated. Fable Foods' funding round closed, and Michael Fox's earlier shoe startup Shoes of Prey is recalled as collapsed.
Grant
$1.3m
Trialling drones and tractors for cost-effective revegetation (1 May 2019)
A University of New England-led project with UK firm BioCarbon Engineering will test drone and tractor seeding for cheaper revegetation of cotton farmland, backed by a $1.3 million government grant won by CRDC.
Funding announcement
Opal Therapeutics Inc and Massachusetts General Hospital enter Joint Development Collaboration and Initiate HIV Immunotherapy Clinical Studies - Therapeutic Vaccine Trials to Start in London, UK
Opal Therapeutics partners with Massachusetts General Hospital on an HIV immunotherapy collaboration as human trials begin in London; the biotech counts Alloy Ventures, Alta Partners and GBS Ventures among its backers.